News

News Archive

Menarini’s Sustenium product line launched on Tmall

Menarini’s Sustenium product line launched on Tmall

Menarini’s Sustenium product line launched on Tmall

Menarini Consumer Healthcare has entered a partnership with Alibaba, one of the world’s leading technology companies, by opening a flagship store on Tmall

61st ASH Congress 2019: Menarini Ricerche presents the latest updates about the First In Human clinical trial of SEL24/MEN1703

61st ASH Congress 2019: Menarini Ricerche presents the latest updates about the First In Human clinical trial of SEL24/MEN1703

61st ASH Congress 2019: Menarini Ricerche presents the latest updates about the First In Human clinical trial of SEL24/MEN1703

Menarini Ricerche is progressing with the clinical development of SEL24/MEN1703, and will be presenting the design of the ongoing First In Human clinical trial DIAMOND-01 (NCT03008187)...
ESMO Annual Meeting 2019: Menarini Ricerche presents the preclinical characterization of MEN1611, a novel PI3K inhibitor in development for the treatm

ESMO Annual Meeting 2019: Menarini Ricerche presents the preclinical characterization of MEN1611, a novel PI3K inhibitor in development for the treatm

ESMO Annual Meeting 2019: Menarini Ricerche presents the preclinical characterization of MEN1611, a novel PI3K inhibitor in development for the treatment of breast cancer.

Promising results from the preclinical study conducted by Menarini Ricerche on MEN1611, a potent and selective orally available phosphatidylinositol 3-kinase (PI3K) inhibitor currently...
Menarini Ricerche announces publication of pre-clinical data of the first-in-class antibody-drug conjugate MEN1309/OBT076,

Menarini Ricerche announces publication of pre-clinical data of the first-in-class antibody-drug conjugate MEN1309/OBT076,

Menarini Ricerche announces publication of pre-clinical data of the first-in-class antibody-drug conjugate MEN1309/OBT076, currently in Phase I clinical development

Today announced the publication of the results of a non-clinical study describing the characterization of the anti-CD205 Antibody-Drug Conjugate (ADC) MEN1309/OBT076

1234

Select a Year from the Archive

Our values

Our values

Everyday we put our values into action. 4 values, which have given life to Menarini and have shaped its history.

Read More

Our values

Go to Follow our blog

Follow our blog

Discover our stories from all over the world

Read More